Skip to content

13F-HR filed by Integral Health Asset Management, LLC

Integral Health Asset Management, LLC filed this 13F-HR for the quarter ended 2020-03-31, filed 2020-05-15, with 51 holding rows worth $227,032,000.

Accession
0001420506-20-000652
Filed
2020-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2020

A holdings report, 51 entries on the cover page, a total value of $227,032,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $227,032,000 with VALUE read as thousands by filing date, 13F file number 028-19946. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Medtronic PlcG5960L103COM115,000$10,371,000thousands by filing date
CENTENE CORP DEL COM15135B101Stock170,000$10,100,000thousands by filing date
Merck & Co.,Inc.58933Y105COM130,000$10,002,000thousands by filing date
Bristol-Myers Squibb Company110122108COM175,000$9,755,000thousands by filing date
QUEST DIAGNOSTICS INC COM74834L100Stock120,000$9,636,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM110,000$9,295,000thousands by filing date
ASTRAZENECA PLC SPONSORED ADR046353108ADR190,000$8,485,000thousands by filing date
CATALENT INC USD 0.01148806102COM150,000$7,793,000thousands by filing date
CHEMOCENTRYX INC16383L106COM190,000$7,634,000thousands by filing date
ENCOMPASS HEALTH CORP COM29261A100Stock115,000$7,363,000thousands by filing date
LHC GROUP50187A107COM50,000$7,010,000thousands by filing date
Danaher Corporation235851102COM50,000$6,921,000thousands by filing date
GW PHARMACEUTICALS PLC36197T103ADS75,000$6,568,000thousands by filing date
MASIMO CORP COM574795100Stock35,000$6,199,000thousands by filing date
NOVARTIS AG SPONSORED ADR66987V109ADR70,000$5,772,000thousands by filing date
BECTON DICKINSON & CO075887109COM25,000$5,744,000thousands by filing date
AGIOS PHARMACEUTICALS INC00847X104COM150,000$5,322,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM170,000$4,882,000thousands by filing date
EXACT SCIENCES CORP COM30063P105Stock80,000$4,640,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW110,000$4,620,000thousands by filing date
Boston Scientific Corporation101137107COM125,000$4,079,000thousands by filing date
NEVRO CORP64157F103COM40,000$3,999,000thousands by filing date
DENTSPLY SIRONA INC24906P109COM100,000$3,883,000thousands by filing date
CYTOKINETICS INC23282W605COM NEW320,000$3,773,000thousands by filing date
CHEWYINCCLASSCLASSA16679L109STOK100,000$3,749,000thousands by filing date
WALGREENS BOOTS ALLIANCE INC931427108COM80,000$3,660,000thousands by filing date
Abbott Laboratories002824100COM45,000$3,551,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM60,000$3,509,000thousands by filing date
Intuitive Surgical,Inc.46120E602COM7,000$3,466,000thousands by filing date
DICERNA PHARMACEUTICALS INC253031108COM185,000$3,398,000thousands by filing date
REVVITY INC714046109COM45,000$3,388,000thousands by filing date
MCKESSON CORP COM58155Q103Stock25,000$3,382,000thousands by filing date
NOVO-NORDISK A S ADR670100205ADR55,000$3,311,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM40,000$3,075,000thousands by filing date
EXELIXIS INC COM30161Q104Stock150,000$2,583,000thousands by filing date
UnitedHealth Group Inc91324P102COM10,000$2,494,000thousands by filing date
10X GENOMICS INC CL A COM88025U109Stock40,000$2,493,000thousands by filing date
ALKERMES PLCG01767105SHS150,000$2,163,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM95,000$2,110,000thousands by filing date
KARYOPHARM THERAPEUTICS INC48576U106COM100,000$1,921,000thousands by filing date
EXELIXIS INC30161Q904COM100,000$1,722,000thousands by filing date
BRISTOL-MYERS SQUIBB CO110122157RIGHT 99/99/9999450,000$1,710,000thousands by filing date
ARVINAS INC04335A105COM40,000$1,612,000thousands by filing date
DENALI THERAPEUTICS INC COM24823R105Stock90,000$1,576,000thousands by filing date
HUMANA INC COM444859102Stock5,000$1,570,000thousands by filing date
AKEBIA THERAPEUTICS INC00972D105COMMON STOCK200,000$1,516,000thousands by filing date
MINERVA NEUROSCIENCES INC COM NEW603380106Stock250,000$1,505,000thousands by filing date
AKERO THERAPEUTICS INC00973Y108COM60,000$1,272,000thousands by filing date
HALOZYME THERAPEUTICS INC COM40637H109Stock50,000$900,000thousands by filing date
AMARIN CORPORATION PLC -ADR023111906ADR200,000$800,000thousands by filing date
PFENEX INC717071104COM85,000$750,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-20-000652this filing2020-05-15acceptance time not in the bulk data set